Even on a flat day for the overall market, these stocks climbed substantially. Find out why.
News & Analysis: Flamel Technologies
Shares of the French biopharma Flamel Technologies rose by more than 16% today. Here's why.
Biopharma stocks are starting to pull back in a big way. Flamel Technologies and Pfizer, though, are two good names to pick up on any weakness. Here's why.
These five small-cap growth stocks could soar in 2015. Here's why.
Three Fools outline the reasons they think these biotech stocks could be top buys in February.
The stock market closed at record highs today, and these three stocks helped lead the way. Find out more about why they soared.
On a topsy-turvy day in the stock market, these three stocks posted impressive gains. Find out more about what made them soar.
These underrated stocks could be tomorrow's big winners.
Is this meaningful? Or just another movement?
More than anything, it's containment that's key to the health of the market.